IVX vs MEM

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

IVX

INVION FPO [IVX]

41LOW

MEM

MEMPHASYS FPO [MEM]

41LOW

Score Breakdown

IVX MEM
Technical
57
55
Catalyst
53
55
Sentiment
50
50
Fundamental
17
11
Momentum
54
61
Risk Gate
45
27

Key Metrics

IVX Metric MEM
$7.3MMarket Cap$14.2M
76KAvg Volume (20d)1.9M
N/AShort InterestN/A
$0.20052-Week High$0.011
$0.07552-Week Low$0.003
+0.0%Daily Change+11.1%
$0.075Entry Price$0.005
-111.5%ROE-87.4%
N/AProfit MarginN/A

Active Signals

IVX Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (0.2 quarters)
●Pre-revenue with limited cash
●Piotroski F-Score weak (2/9, low-confidence approx)

MEM Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Volume surging at 3.1x normal while price falls — heavy selling pressure
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (0.6 quarters)
●Very high P/S ratio (66.5x)
●Revenue in sharp decline (-96%)

Ask Scout AI to compare IVX and MEM in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IVX Full Analysis → MEM Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).